Skip to content
Open access · OA via Europe PMC

Emerging Roles of FGFR3 and FGF23-Associated Signaling in Renal Fibrosis: Molecular Integration, Clinical Correlates, and Therapeutic Perspectives.

Fu Y, Wang H, Wang L, Wang H.

Biomolecules · 2026

Abstract

Renal fibrosis represents the final common pathway of chronic kidney disease (CKD) progression and remains a major therapeutic challenge. Fibroblast growth factor receptor 3 (FGFR3) has emerged as a context-dependent component of fibroblast growth factor (FGF) signaling, but its renal role remains incompletely defined because direct receptor-specific evidence is scarce. This review integrates kidney-specific FGFR3 studies with endocrine FGF23-Klotho biology and broader FGF/FGFR networks using an explicit evidence hierarchy. Current direct renal evidence is limited to two 2025 experimental studies: an FGF18-associated FGFR3-AMPK-NOX4 program that attenuated folic acid-induced fibrosis, and a single toxicant model reporting an FGF9-FGFR3-PI3K/Akt program associated with fibroblast proliferation. The latter requires independent replication before generalization beyond toxicant nephropathy. By contrast, physiological renal FGF23 signaling is best established through FGFR1c-α-Klotho, whereas the strongest evidence for Klotho-independent pathological FGF23 signaling involves FGFR4 in cardiovascular tissues; direct evidence that FGF23 promotes renal fibrosis specifically through FGFR3 is lacking. Accordingly, FGFR3 should be viewed as an emerging, ligand- and compartment-dependent signaling component rather than a validated CKD therapeutic target. Future priorities include human kidney spatial and phosphoproteomic profiling, cell-specific FGFR3 perturbation, longitudinal FGF23/Klotho biomarker studies, and mechanism-based evaluation of FGFR-directed strategies with integrated renal and mineral-metabolism endpoints.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3390/biom16101431
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Y, F., H, W., L, W., &amp; H., W. (2026). Emerging Roles of FGFR3 and FGF23-Associated Signaling in Renal Fibrosis: Molecular Integration, Clinical Correlates, and Therapeutic Perspectives. <em>Biomolecules</em>. https://doi.org/10.3390/biom16101431
Vancouver
Y F, H W, L W, H. W. Emerging Roles of FGFR3 and FGF23-Associated Signaling in Renal Fibrosis: Molecular Integration, Clinical Correlates, and Therapeutic Perspectives. Biomolecules. 2026. doi:10.3390/biom16101431.
BibTeX
@article{fu2026Emergi, title = {Emerging Roles of FGFR3 and FGF23-Associated Signaling in Renal Fibrosis: Molecular Integration, Clinical Correlates, and Therapeutic Perspectives.}, author = {Fu Y and Wang H and Wang L and Wang H.}, journal = {Biomolecules}, year = {2026}, doi = {10.3390/biom16101431}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings